Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Shining a Spotlight: Catching up with 2018 IPC Fellow, Jia Qi Chen, PhD

Jia Qi Chen, MD, PhD

Zhejiang University School of Medicine

Zhejiang, China

IPC Jr. Councilor

Bio

In this edition of our Fellows Spotlight, we reconnect and catch up with 2018 IPC Fellow, Dr. Jia Qi Chen. Dr. Chen is a dermatologic fellow at the Second Affiliated Hospital of Zhejiang University School of Medicine. Holding a PhD in Dermatology from Zhejiang University, she completed her residency at the same institution. Dr. Chen is an accomplished lead author of three peer-reviewed manuscripts. Her expertise lies in investigating the pathogenesis of psoriasis, showcasing a dedicated focus in her dermatology education.

As a 2018 Fellow, she studied with IPC Councilor Dr. Curdin Conrad, MD, at the University Hospital of Lausanne (CHUV) in Switzerland and attended the 27th European Academy of Dermatology and Venereology (EADV) Congress in Paris. Dr. Chen now shares her reflections on the IPC International Fellowship Program experience and its impact on her career.

The IPC Fellowship Experience

Having Curdin Conrad as my mentor was such a stroke of luck! I spent a month at CHUV, in Lausanne, Switzerland. Dr. Conrad took me through his specialized clinic every week, demonstrating how he approaches patient care. His profound respect for patients left a lasting impression on me, shaping my approach as a dermatologist in the clinic. Additionally, I had around 15 days in his lab, providing me with a preliminary understanding of his research field.

“I owe a special thanks to the IPC Fellowship Program, as I believe I wouldn’t have secured the scholarship without its valuable support.” 

Post-Fellowship Achievements

Winning the Swiss Government Excellence Scholarship (FCS) for the academic year 2020/2021 was a significant achievement for me. Throughout that academic year, I spent an entire year in CHUV in Dr. Conrad’s lab, creating lasting memories. I owe a special thanks to the IPC Fellowship Program, as I believe I wouldn’t have secured the scholarship without its valuable support.

Applying Knowledge in the Field

During the program, I acquired valuable research skills, such as independently conducting FISH in situ. This year, I went further and applied for the National Natural Science Foundation of China. Fortunately, I secured a grant, which will significantly enhance my research on the pathogenesis of psoriasis, with a particular focus on pustular psoriasis.

Navigating Career Challenges

After the Fellowship, I encountered several career challenges. I vividly recall the nervous moments during the application for the FCS. Thankfully, Dr. Conrad provided support through communications and a stellar recommendation letter. This assistance alleviated my anxiety, and eventually, I received the good news!

Evolving Perspectives on the Industry

Biological agents have rapidly gained prominence worldwide, simplifying the treatment of moderate to severe psoriasis. However, this widespread use has introduced new challenges, such as paradoxical psoriasis. In our department, we’ve initiated using FACS to identify potential abnormal cytokines in patients’ lesions. This allows us to tailor treatment by selecting the appropriate biologics or small molecular inhibitors for each patient.

Advice for Future Fellowship Participants

Staying on-site for more than a month – no matter what – would be my top tip! It’s essential to connect with other professionals—it sparks fresh ideas, streamlines work, and clears up any misunderstandings. Being proactive during the program is also crucial, and trust me, the rewards will follow.

If you are a young dermatologist or researcher passionate about improving the lives of people with psoriasis and want to expand your horizons, consider applying to participate in IPC’s International Fellowship Program. Applications for the 2025 program will open in September 2024.

Categories

Recent Posts

Psoriasis and Metabolic Health: What IPC’s Latest Publication Means for Clinical Practice

Challenging Patient Interactions: What’s Really Behind the ‘Difficult’ Label — A Conversation with Dr. John Koo

IPC Welcomes New Councilors Dr. Steven Fakharzadeh and Dr. Rodrigo Garcia Salinas

Also Read

A grid of eight professionally dressed people, four men and four women—each an IPC Fellowship participant—in individual portrait photos, set against a colorful geometric background.
Psoriasis education

Meet IPC’s 2026 International Fellows

Meet the 2026 IPC International Fellows, eight internationally selected clinicians and researchers advancing evidence-based psoriasis care and global collaboration through the International Psoriasis Council.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.

WATCH NOW

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.

WATCH NOW

Thursday, July 13, 2026

New Take Tens on Psoriatic Arthritis

IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.

IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.

WATCH NOW

Wednesday, July 8, 2026